ArticleFrontiers in oncology2022

Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study.

Pietro De Placido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.